News

The Addplan 6.0 PE provides the statistical methodology, simulation and analysis tools for adaptive clinical trials that include an enrichment design. The adaptive trial software will be of

The company now offers Megavitamin No 1 Pack, which provides a 28-day supply of all the essential vitamins, minerals, extra herbs, nutrients and amino acids. Another new product

DFH will work with the NIAID’s Division of AIDS (DAIDS) under a material evaluation agreement that will allow for the pre-clinical assessment of the promising maturation inhibitor compounds.

The Afirma Thyroid FNA Analysis combines cytopathology assessment of thyroid nodule fine needle aspiration (FNA) samples with the Afirma Gene Expression Classifier for improved thyroid nodule diagnosis. The

LunaRich is a whole soy powder containing five to ten times more lunasin, a peptide found naturally in soy than the industry standard. Previous studies demonstrated that lunasin

The platform delivers data management, organization and subsequent connection with downstream development, while supporting regulatory compliance and protecting intellectual property. It incorporates the ability to search across experiments,

As part of the agreement, Catalent will engineer a cell line expressing Nascent’s Pritumumab antibody using Catalent’s GPEx technology. Catalent will produce purified monoclonal antibody to support Nascent’s

Blood test was initially cleared to diagnose and distinguish methicillin resistant and methicillin sensitive Staphylococcus aureus (MRSA vs. MSSA) in positive blood cultures. The test is now cleared

As per the agreement, Vanda will pay an initial license fee of $1m to Eli Lilly and will be responsible for all development costs. Lilly is also eligible